EIT Health invites organisations from industry, education and research to submit proposals for the development of a new EIT Label-certified Biotech pathway within the Certified Innovation Path (CIP) portfolio, complementing the existing Health Data, Digital Medical Devices and High Value Care pathways.
Funded projects will design and deliver personalised learning courses for graduates and professionals across the health biotechnology value chain. The pathway will equip participants with the innovation, entrepreneurship and biotech expertise needed to translate scientific advances into scalable, market-ready healthcare solutions across Europe.
The call information and supporting documents are now available to help applicants prepare their proposals. Access to the application platform will open on 15 July 2026.
Who can apply?
A consortium of minimum two Higher Education Institutions (HEIs) established in two different eligible Member States, of which:
- At least one HEI must be established in an EIT RIS region; and
- At least one of the participating Higher Education Institutions must be authorised to award ECTS credits for the repurposed courses.
- At least one non-academic or industry partner, expected to actively contribute to the curriculum of the repurposed courses and to the supervision of learner assessment. Active and substantive involvement of non-academic or industry partners is essential, as a highly integrated, innovative learning by doing approach is a core principle of EIT Labelled Fellowships. Learners are expected to work both individually and in interdisciplinary teams, typically addressing authentic challenges articulated by industry and other non-academic partners.
About the course
Proposed courses must aim to:
- Equip participants to navigate and apply Europe’s evolving regulatory and policy landscape, including the EU Biotech Act, Clinical Trials Regulation and MDR/IVDR, with a focus on translation and early scaleup.
- Integrate advanced biotech and translational expertise with EIT Labelled innovation, entrepreneurship and leadership competencies, enabling real-world implementation of biotech innovation.
- Strengthen cross border collaboration, mobility and industry engagement, connecting European research, clinical, manufacturing and investment ecosystems through applied learning and capstone projects.
- Enable participants to articulate and demonstrate projected scientific, clinical and economic value across development stages, and to align development strategies with financing, partnering and market access considerations.
What we fund
Up to 240 000 € per awarded project
Expected outcomes
- Graduates from EIT-labelled programmes: 150 CIP graduates by 2028 – Across all pathways
- EIT RIS Graduates from EIT labelled programmes: 30 CIP graduates by 2028 – 20% of graduates)
Key Dates
- Call opens on: 24 June 2026
- Call closes on: 16 September 2026
- Evaluation Period: 16 September 2026 – 29 October 2026
- Call Information Session: 15 July 2026 – 10:30 – 11:30 CET – Register here
- Open Q&A Session: 03 September 2026 – 11:00 CET – Register here
- Final Award Notification: 11 November 2026
- Project Start Date: 01 January 2026
Where to find out more
Click here for the official call document and supporting documents
How to apply
From 15 July 2026.
- Step 1: Register your organisation in the EU Funding & tender opportunities portal to obtain the nine-digit Participant Identification Code (PIC number). If you do not know if your organisation already has a PIC number, you can verify directly on the EU Portal whether your organisation is already registered.
- Step 2: Apply to the call via EIT Health’s application platform. Click on the “Apply” button below.